These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A review of current technology used in evaluating visual function in glaucoma. Turalba AV; Grosskreutz C Semin Ophthalmol; 2010; 25(5-6):309-16. PubMed ID: 21091017 [TBL] [Abstract][Full Text] [Related]
4. Risk assessment in the management of patients with ocular hypertension. Weinreb RN; Friedman DS; Fechtner RD; Cioffi GA; Coleman AL; Girkin CA; Liebmann JM; Singh K; Wilson MR; Wilson R; Kannel WB Am J Ophthalmol; 2004 Sep; 138(3):458-67. PubMed ID: 15364230 [TBL] [Abstract][Full Text] [Related]
5. Standard automated perimetry and algorithms for monitoring glaucoma progression. Scuderi GL; Cesareo M; Perdicchi A; Recupero SM Prog Brain Res; 2008; 173():77-99. PubMed ID: 18929103 [TBL] [Abstract][Full Text] [Related]
6. Disease progression and the need for neuroprotection in glaucoma management. Varma R; Peeples P; Walt JG; Bramley TJ Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311 [TBL] [Abstract][Full Text] [Related]
7. Focusing on glaucoma progression and the clinical importance of progression rate measurement: a review. Rossetti L; Goni F; Denis P; Bengtsson B; Martinez A; Heijl A Eye (Lond); 2010 Oct; 24 Suppl 1():S1-7. PubMed ID: 20944656 [TBL] [Abstract][Full Text] [Related]
8. A critical discussion of the rates of progression and causes of optic nerve damage in glaucoma: International Glaucoma Think Tank II: July 25-26, 2008, Florence, Italy. Caprioli J; Zeyen T J Glaucoma; 2009 Aug; 18(6 Suppl):S1-21. PubMed ID: 19680047 [TBL] [Abstract][Full Text] [Related]
9. The challenges of monitoring glaucoma progression. Termote K; Zeyen T Bull Soc Belge Ophtalmol; 2010; (314):25-32. PubMed ID: 20480748 [TBL] [Abstract][Full Text] [Related]
11. The psychophysics of glaucoma: improving the structure/function relationship. Anderson RS Prog Retin Eye Res; 2006 Jan; 25(1):79-97. PubMed ID: 16081311 [TBL] [Abstract][Full Text] [Related]
12. Comparison of mean deviation with AGIS and CIGTS scores in association with structural parameters in glaucomatous eyes. Naka M; Kanamori A; Tatsumi Y; Fujioka M; Nagai-Kusuhara A; Nakamura M; Negi A J Glaucoma; 2009; 18(5):379-84. PubMed ID: 19525728 [TBL] [Abstract][Full Text] [Related]
13. Blue-on-yellow perimetry in the diagnosis of glaucoma. Teesalu P Acta Ophthalmol Scand; 1999 Jun; 77(3):364-5. PubMed ID: 10406168 [No Abstract] [Full Text] [Related]
15. Bilateral ocular hypertension with rapidly progressive optic neuropathy in a teen. Hua LV; Byrne E; Yudcovitch L Optom Vis Sci; 2009 Sep; 86(9):E1117-26. PubMed ID: 19661835 [TBL] [Abstract][Full Text] [Related]
16. Spatially consistent, localized visual field loss before and after disc hemorrhage. De Moraes CG; Prata TS; Liebmann CA; Tello C; Ritch R; Liebmann JM Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4727-33. PubMed ID: 19458330 [TBL] [Abstract][Full Text] [Related]
17. Detection of visual field progression in glaucoma. Kovalska M; Grieshaber MC; Schötzau A; Katamay R; Hauenstein D; Flammer J; Orgül S Klin Monbl Augenheilkd; 2008 May; 225(5):342-5. PubMed ID: 18454368 [TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of mesopic color perimetry in early glaucoma]. Fedorovskaia LI Vestn Oftalmol; 1988; 104(4):12-4. PubMed ID: 3218022 [No Abstract] [Full Text] [Related]